寧波銀行(002142.SZ)“寧行轉債”轉股數額累計達轉股前公司已發行股份總額10%
格隆匯8月15日丨寧波銀行(002142.SZ)公佈,截至2019年8月14日,公司發行的可轉換公司債券“寧行轉債”累計有91.095億元轉換成公司已發行的A股股票(股票簡稱:寧波銀行,代碼:002142),轉股股數累計為5.09億股,佔公司可轉換公司債券開始轉股前公司已發行股份總數50.697億股的10.04%,尚有8.90億元存量的“寧行轉債”,佔“寧行轉債”發行總量100億元的8.90%。至此,公司總股本為55.79億股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.